BALTIMORE, Aug. 14, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced that the new BD MAX™ MRSA molecular test has received a Moderate ...

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: Genomic Vision (FR0011799907 – GV – the “Company”), a Euronext-listed biotechnology company that develops products and services for the highly ...

ABBOTT PARK, Ill., Nov. 3, 2010 /PRNewswire/ -- Abbott today announced it has received a 2010 Chicago Innovation Award for its ARCHITECT HIV Ag/Ab Combo assay, the first test approved in the United ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has categorized its Ionify® 25-Hydroxy Vitamin D total assay as "Moderate Complexity" under the ...

ALBUQUERQUE, N.M., Oct. 28, 2024 /PRNewswire/ -- T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases, announced today that it ...

Roche (RHHBY) announced that the U.S. Food and Drug Administration has categorized its Ionify 25-Hydroxy Vitamin D total assay as “Moderate ...

SAN DIEGO--(BUSINESS WIRE)--Assay Depot announced today that it raised $1.7 million from private investors. The funds will be used to expand the company's cloud-based pharmaceutical research platform.

Epidermal growth factor receptor intron 1 (CA)n dinucleotide repeat polymorphism and mutations associated with the responsiveness of molecular targeted therapy in lung cancer Although specific to ...

DUBLIN--(BUSINESS WIRE)--The "Global Oxidative Stress Assay Market for Pharmaceutical Industry 2018-2022" report has been added to ResearchAndMarkets.com's offering. The global oxidative stress assay ...

(RTTNews) - Acumen Pharmaceuticals (ABOS), Monday reported that using a plasma pTau217 screening assay in its Phase?2 ALTITUDE-AD study of sabirnetug reduced trial screening costs by about 40 percent ...